Growing community of inventors

Uxbridge Middlesex, United Kingdom

Paul Bryan Wren

Average Co-Inventor Count = 9.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Paul Bryan WrenFeng Ren (2 patents)Paul Bryan WrenXichen Lin (2 patents)Paul Bryan WrenTing Yang (2 patents)Paul Bryan WrenHongfu Lu (2 patents)Paul Bryan WrenWeichun Chen (2 patents)Paul Bryan WrenZhongmiao Xu (2 patents)Paul Bryan WrenEbere F Igboko (2 patents)Paul Bryan WrenLindong Zhu (1 patent)Paul Bryan WrenLingdong Zhu (1 patent)Paul Bryan WrenWeichun Chen (0 patent)Paul Bryan WrenXichen Lin (0 patent)Paul Bryan WrenPaul Bryan Wren (2 patents)Feng RenFeng Ren (23 patents)Xichen LinXichen Lin (22 patents)Ting YangTing Yang (8 patents)Hongfu LuHongfu Lu (7 patents)Weichun ChenWeichun Chen (4 patents)Zhongmiao XuZhongmiao Xu (4 patents)Ebere F IgbokoEbere F Igboko (2 patents)Lindong ZhuLindong Zhu (1 patent)Lingdong ZhuLingdong Zhu (1 patent)Weichun ChenWeichun Chen (0 patent)Xichen LinXichen Lin (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Glaxosmithkline Intellectual Property Development Limited (2 from 230 patents)


2 patents:

1. 10336719 - 1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors

2. 10106515 - 1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…